CDMO Valuation

Avid Bioservices Inc

Add to Watchlist

Advanced Chart

12.490

0.000(0.000%)

Overview
Forecast
Valuation

CDMO Relative Valuation

CDMO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CDMO is overvalued; if below, it's undervalued.

Historical Valuation

Avid Bioservices Inc (CDMO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.57 is considered Undervalued compared with the five-year average of 6.75. The fair price of Avid Bioservices Inc (CDMO) is between 34.39 to 49.29 according to relative valuation methord. Compared to the current price of 12.49 USD , Avid Bioservices Inc is Undervalued By 63.68%.

Relative Value

Fair Zone

34.39-49.29

Current Price：12.49

63.68%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

17.83

P/B

Median3y

6.53

Median5y

11.63

-1.21

FCF Yield

Median3y

-7.55

Median5y

-4.12

Competitors Valuation Multiple

The average P/S ratio for CDMO's competitors is 43.10, providing a benchmark for relative valuation. Avid Bioservices Inc Corp (CDMO) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 31.84%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap